“…Ethanol exacerbates this process by enhancing the synthesis of hyaluronic acid (HA), a key ECM glycosaminoglycan, thus intensifying hepatic pro-fibrotic characteristics. 89 In fatty liver patients, ethanol promotes HA-dependent HSC activation, altering hepatic ECM and accelerating ALD progression. 89 …”